Overview of the biopharmaceutical moieties, developed with technology from the Protein Technologies consortium, in (pre)clinical development or marketed.

F4+ ETEC targeting VHH & IgA-Fc -fusion antibody 

An oral feed-based passive immunization strategy against a pathogen (ETEC) causing post-weaning infections in young piglets. 


Enzybiotics are a new breed of antimicrobials. They can be functionally optimized using a modular design- and synthesis approach. The VersaTile platform uses this specific approach for neofunctionalization of proteins to create other, new biopharmaceutical molecules.